Huntington’s disease

Visual of a brain
Biotech

Roche ends 2 Huntington’s programs, including Ionis ASO

Both drugs are antisense oligonucleotides targeting the huntingtin gene, which causes Huntington’s when a mutation leads to its expansion over time.
Darren Incorvaia Jul 9, 2026 2:40pm
bridge

Can’t plausible mechanism principles apply to uniQure?

Apr 15, 2026 4:00am
FDA stop sign

Senior FDA official fires back at uniQure amid controversy

Mar 5, 2026 3:33pm
tennis racket hitting ball

UniQure, FDA back-and-forth intensifies

Mar 5, 2026 11:55am
stop train halt end road block railway

FDA demands ph. 3 trial of uniQure's Huntington's gene therapy

Mar 2, 2026 10:45am
uturn

uniQure's gene therapy for Huntington's hits FDA roadblock

Nov 3, 2025 10:03am